BUSINESS
Abbott gets approval to launch 5-minute COVID-19 test for use almost anywhere
Abbott's testing kit will be major game changer, as currently even in advanced countries like US and Europe, it is taking 24-48 hours to get laboratory test result.
BUSINESS
COVID-19 impact | Private hospitals hit hard, steep drop in OPD footfalls
Even India's largest healthcare chains like Apollo Hospitals has warned about the "total crash of the system" if government doesn't step in .
BUSINESS
Coronavirus: Laurus Labs to supply Hydroxychloroquine for clinical trials in the US
The company has received an approval from the US Food & Drug Administration (USFDA) to market Hydroxychloroquine Sulphate tablets
BUSINESS
Coronavirus pandemic | IFPMA says its members developing vaccines
"We are sending a clear signal of how seriously industry is taking the pandemic and the need to act as one team," said David Ricks, Chairman and CEO of Eli Lilly and IFPMA President.
BUSINESS
Coronavirus pandemic: DCGI to expedite approvals of COVID-19 drugs, vaccines
The drug regulator said in case of emergency, they are would granting import license without registration certificate subject to approval of government.
BUSINESS
Coronavirus pandemic: Rajasthan's Bhilwara district authorities invoke special powers to take over five private hospitals
The takeover of private hospitals by the district administration using special powers conferred under Epidemic Disease Act, 1897 may possibly set a precedent for other district authorities to follow suit in the coming days.
BUSINESS
Apollo Hospitals scales up group assets to help in fight against COVID-19
The company said its infrastructure would help to give advanced care to over 2000 COVID-19 patients a month.
BUSINESS
Coronavirus pandemic: Pharma body seeks govt intervention to end disruption caused by lockdown
IPA drew the attention of the government towards the mistreatment of pharmaceutical industry workers by police.
BUSINESS
Coronavirus pandemic | Pharma companies ask sales representatives to work from home
India's largest drug maker Sun Pharma which has field force 9,500 plus covering over 400,000 doctors in every nook and corner of the country said it is encouraging employees in the field globally to work from home.
BUSINESS
RPG Life Sciences banking on legacy brands and new launches
Managing Director Yugal Sikri expressed confidence about keeping up the growth momentum.
BUSINESS
Cess on imported medical devices to make healthcare costlier
With an additional 5% health cess, the new customs duty becomes 12.5 percent, this is in addition to the education cess levied on importers.
BUSINESS
Budget 2020: Viability gap funding to drive investors toward setting up hospitals under PPP, says Aster's Azad Moopen
"Also the model for establishing medical colleges attached to district hospitals under PPP mode will help solve healthcare access, medical education and availability of doctors," Moopen added.
BUSINESS
Budget 2020 | Healthcare spending sees marginal rise, govt focuses on healthcare infra in small towns
Allocation for Ayushman Bharat scheme remained flat at Rs 6,400 crore.
BUSINESS
Budget 2020: Cess on imported medical devices fails to enthuse domestic manufacturers
“To give impetus to domestic industry, and to generate resource for health services, it is proposed to impose a nominal health cess of 5 percent on imports of specified medical equipment,” said Finance Minister Nirmala Sitharaman in her budget speech.
BUSINESS
Domestic biz helped RPG Life Sciences report 49% YoY rise in Q3 net profit
Domestic business constitutes about two-thirds of company’s revenues grew at 23 percent, and international sales that constitute the rest grew by 26 percent.
BUSINESS
Coronavirus impact: Government prohibits export of all kinds of respiratory masks
There have been concerns about its availability due to spurt in demand.
BUSINESS
Economic Survey 2020: Expenditure on healthcare continues to be flat
The combined Central and state governments spend on healthcare, as percentage of total expenditure had remained flat at 5.3 in last two consecutive financial years
HEALTH-TRENDS
WHO declares coronavirus outbreak as global public health emergency
The decision was taken at the second meeting of the Emergency Committee in Geneva, Switzerland.
BUSINESS
Coronavirus outbreak: Indian drug makers may see disruption of drug supply chain in coming weeks
India imports about $4.5 billion worth of APIs and KSMs from China. These include antibiotics, hormones, vitamins, anti-hypertension and anti-diabetes drugs.
WORLD
Coronavirus update: No confirmed cases in India, Chinese top expert says outbreak may peak in 7-10 days
The Indian government said one suspected case in Jaipur, Rajasthan, had turned out to be negative.
BUSINESS
Dr Reddy's to expand product portfolio in US to fuel future growth
"We will not be dependent on any single product to grow...," said Erez Israeli, CEO of Dr Reddy's said.
BUSINESS
Will follow licensing model to take GBS vaccines into late stage development: Hilleman Labs CEO
GBS is one of the leading cause of maternal and infant mortality. Currently there is no vaccine available in the market to protect pregnant women against GBS, leading to neonatal infections such as pneumonia, septicaemia, meningitis, and urinary tract infections in women.
BUSINESS
Coronavirus outbreak: WHO Southeast Asia rolls out interim guidance to contain disease
Two countries in the WHO South-East Asia Region – Thailand and Nepal - have reported confirmed cases of the new coronavirus
BUSINESS
New launches to help Biocon Biologics reach $1 bn revenue target by FY22: Christiane Hamacher
The biologics segment grew 50 percent year-on-year (YoY) in nine-month period to Rs 1594 crores, led primarily by contributions from Pegfilgrastim and Trastuzumab in US market.
